Agilent to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Agilent Technologies, Inc. (NYSE: A) had its price target raised by analysts at Citigroup Inc. to $165.00. They now have a "buy" rating on the stock.
Genomics in Cancer Care: North American Market Growth Forecasts and Business Opportunities, 2024-2031 [Yahoo! Finance]
Preimplantation Genetic Testing Market to hit USD 1.7 billion by 2032, says Global Market Insights Inc. [Yahoo! Finance]
Agilent Technologies, Inc. (NYSE: A) had its price target lowered by analysts at Bank of America Co. from $153.00 to $150.00. They now have a "neutral" rating on the stock.